Table 1.

Study cohort demographics

Number of patients92
Age (y) (mean ± SD)65.8 ± 5
cT, N (%)cT150 (54)
cT2/342 (46)
PSAi (ng/mL), N (%)<47 (8)
4 ≤ x< 1059 (64)
>1026 (28)
Risk group, N (%)L55 (60)
I32 (35)
H5 (5)
Gleason score, N (%)668 (74)
716 (17)
88 (9)
International prostate symptom score, N (%)<880 (87)
≥ 812 (13)
Volume transrectal ultrasound (cc) (mean ± SD)34 ± 9
BCR, N (%)No event82 (89)
Event10 (11)
RFS (mo) (mean ± SD)No event72 ± 28
Event50 ± 33
OS (mo) (mean ± SD) (median)No event72 ± 28 (70)
Event90 ± 30 (96)
Hormonal therapy pre-implantNo58 (63)
Yes34 (37)